Total Clarity Wealth Management’s Editas Medicine EDIT Stock Holding History

Total Clarity Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,300	Closed	-$27K	–	415
2022 Q2	$27K	Buy	+2,300	New	+$30.8K	0.01%	504
2022 Q1	–	Sell	-2,300	Closed	-$61K	–	391
2021 Q4	$61K	Sell	2,300 -500	-18%	-$17.2K	0.03%	371
2021 Q3	$115K	Buy	+2,800	New	+$153K	0.05%	286
2021 Q2	–	Sell	-2,300	Closed	-$97K	–	332
2021 Q1	$97K	Buy	+2,300	New	+$131K	0.06%	242
2020 Q1	–	Sell	-2,350	Closed	-$70K	–	224
2019 Q4	$70K	Buy	+2,350	New	+$58.7K	0.05%	219

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Total Clarity Wealth Management's EDIT Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 2,300 shares — an estimated $27K sold.

Total Clarity Wealth Management first reported a position in EDIT in Q4 2019 and held it in 5 quarters. The position peaked at $115K in Q3 2021. 264 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

Total Clarity Wealth Management reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 2,300 Editas Medicine shares in Q3 2022, an estimated $27K.
Total Clarity Wealth Management first reported a position in Editas Medicine in Q4 2019 and held it in 5 quarters.
Total Clarity Wealth Management's Editas Medicine position peaked at $115K in Q3 2021.
264 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.